Market news

Tipranks Press Release.

cbdMD Inc (YCBD) reports 20% revenue growth driven by wholesale and Oasis brand momentum, while implementing aggressive cost reductions to lower breakeven and navigate a shifting regulatory landscape.

cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted CBD companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD brands, along with its hemp-derived THC beverage brand Oasis and functional-mushroom brand ATRx Labs, today announced financial results for the third quarter of fiscal year 2026, ended June 30, 2026.

cbdMD, Inc. (NYSE American: YCBD), a leader in hemp-derived wellness, today announced its support for the bipartisan Lawful Hemp Protection Act, introduced July 21 by Rep. Andy Barr (R-KY) and Rep. Angie Craig (D-MN). The legislation would establish a long-term federal regulatory framework for hemp-derived products while preserving consumer access to lawful products. The Company also expressed support for the Administration's call to address the federal hemp definition through pending budget leg

cbdMD, Inc. (NYSE American: YCBD), one of the nation's most recognized and trusted hemp-derived wellness companies, today announced the completion of a self-affirmed Generally Recognized as Safe (GRAS) determination supporting the safe consumption of up to 200 mg per day of cannabidiol (CBD), as delivered in the Company's proprietary broad spectrum hemp extract, in healthy adults, addressing one of the most common questions in the category of how much CBD is safe to consume per day.